Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 593,500 shares, a decline of 10.8% from the November 15th total of 665,100 shares. Based on an average daily trading volume, of 218,500 […]
Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) – Equities research analysts at HC Wainwright issued their Q2 2024 earnings per share estimates for shares of Ikena Oncology in a note issued to investors on Thursday, November 9th. HC Wainwright analyst A. Maldonado expects that the company will post earnings of ($0.44) per share for the […]
Wedbush reiterated their outperform rating on shares of Elevation Oncology (NASDAQ:ELEV – Free Report) in a research report report published on Monday morning, Benzinga reports. They currently have a $5.00 price objective on the stock. Wedbush also issued estimates for Elevation Oncology’s Q4 2023 earnings at ($0.26) EPS, FY2023 earnings at ($1.21) EPS, Q1 2024 […]
Celyad Oncology SA (NASDAQ:CYAD – Get Free Report) shares crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.69 and traded as high as $0.81. Celyad Oncology shares last traded at $0.75, with a volume of 8,985 shares. Celyad Oncology Stock Down 5.1 […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 2,180,000 shares, a decline of 17.7% from the August 31st total of 2,650,000 shares. Based on an average trading volume of 189,900 shares, […]